Periactin is a first‑generation antihistamine with additional antiserotonin and anticholinergic properties. It’s commonly used to relieve allergy symptoms such as sneezing, runny nose, watery eyes, hives, and itching. Clinicians also use it off label for selected patients to stimulate appetite and support weight gain, to help prevent certain pediatric migraines, and as an adjunct in serotonin syndrome. Like many sedating antihistamines, it can cause drowsiness and dry mouth. This guide explains how Periactin works, typical dosing, who should avoid it, potential side effects, and key drug interactions so you can use it safely and effectively.
Periactin is primarily prescribed for allergy relief. As an H1 antihistamine, it helps calm classic symptoms of allergic rhinitis (sneezing, runny or stuffy nose, watery eyes) and urticaria (hives) by blocking histamine at receptor sites. Many patients notice reductions in itching and skin redness within hours of the first dose. Because it crosses the blood–brain barrier, Periactin can also be sedating, which some people find helpful when nighttime itching or allergies disrupt sleep.
Beyond allergy control, clinicians use cyproheptadine off label in select scenarios. Appetite stimulation and weight gain support are common reasons, especially in underweight adults or children where other causes of poor intake have been addressed. Pediatric neurologists sometimes use Periactin to help prevent migraine headaches, particularly in younger patients when other options are poorly tolerated. In hospital settings, it can be used as part of the management of serotonin syndrome because of its antiserotonergic effects. Always discuss off‑label use with your clinician to ensure it’s appropriate for you.
Periactin blocks H1 histamine receptors, reducing the inflammatory cascade responsible for itching, swelling, and nasal symptoms. It also antagonizes serotonin (notably 5‑HT2) receptors and has anticholinergic activity. These combined actions explain its clinical profile: relief of allergic symptoms, appetite stimulation for some users, potential utility in migraine prevention, and usefulness as an adjunct in serotonin toxicity. The same central effects contribute to common side effects such as drowsiness, slowed reaction time, and dry mouth.
Dosing depends on age, condition being treated, and individual response. For allergy symptoms in adults, a typical dose is 4 mg three times daily, with some patients requiring up to 4 mg four times daily. The usual adult maximum is 32 mg per day. For children, dosing is lower and age‑specific: ages 2–6 years often start at 2 mg two to three times daily (maximum 12 mg/day), and ages 7–14 years commonly use 4 mg two to three times daily (maximum 16 mg/day). Periactin is not recommended for infants younger than 2 years.
When Periactin is used off label for appetite stimulation or pediatric migraine prevention, clinicians individualize the plan. Many start with lower doses to minimize daytime sedation, sometimes giving a larger portion at bedtime. Take Periactin with or without food, but try to be consistent. Do not exceed your prescribed total daily dose. If sedation is troublesome, ask your clinician whether you can shift more of the dose to the evening or reduce the daytime dose. Never give Periactin to a child without specific pediatric guidance.
Because Periactin can cause drowsiness and slowed reaction time, avoid driving, operating machinery, or other tasks requiring full alertness until you know how you respond. Alcohol, cannabis, benzodiazepines, opioids, sleep medications, and other sedating drugs can intensify this effect. Its anticholinergic properties can worsen dry mouth, constipation, blurred vision, and urinary retention, particularly in older adults and those with prostate enlargement.
Use caution if you have asthma, chronic obstructive pulmonary disease, cardiovascular disease, glaucoma (especially narrow‑angle), increased intraocular pressure, thyroid disease, gastrointestinal obstruction, or a history of urinary retention. Older adults and children can be more sensitive to both sedation and paradoxical excitation. During pregnancy, many clinicians avoid sedating antihistamines unless the benefits clearly outweigh risks; discuss options with your obstetric provider. Antihistamines can pass into breast milk and may affect milk supply or cause infant irritability—seek lactation‑specific guidance before use. Do not use for newborns or premature infants.
Do not use Periactin if you are allergic to cyproheptadine or any component of the formulation. It is contraindicated in newborns and premature infants, in nursing mothers per many labels, and in patients with narrow‑angle glaucoma, urinary retention, peptic ulcer with stenosis, or pyloroduodenal obstruction. Concurrent use with monoamine oxidase inhibitors (MAOIs) is generally contraindicated due to the risk of intensified anticholinergic and CNS effects. Periactin should not be used during an acute asthma attack. If you’re unsure whether a condition applies to you, consult a clinician before starting therapy.
Common side effects include drowsiness, dizziness, fatigue, dry mouth, constipation, blurred vision, and increased appetite with potential weight gain. Some users experience nausea, upset stomach, or mild headache as they adjust to therapy. Because Periactin is sedating, morning grogginess and slowed reflexes are possible, particularly with daytime dosing. In children, paradoxical CNS stimulation—restlessness, irritability, or insomnia—can occur.
Less common but important effects include difficulty urinating (especially in men with enlarged prostate), orthostatic lightheadedness, palpitations, confusion (more likely in older adults), photosensitivity, or thickened bronchial secretions. Very rare events such as hepatic dysfunction or blood dyscrasias have been reported with sedating antihistamines. Seek urgent medical care for severe dizziness or fainting, visual changes from acute glaucoma, severe constipation or abdominal pain, hallucinations, seizures, rash with swelling or trouble breathing, or any symptom that feels severe or rapidly worsening.
Periactin adds to the sedative burden of alcohol, benzodiazepines, opioids, barbiturates, sleep aids, antipsychotics, and other antihistamines. Combining these can markedly increase drowsiness, confusion, and fall risk. Avoid concurrent MAOIs due to heightened anticholinergic and CNS effects. Additive anticholinergic effects may occur with tricyclic antidepressants, antispasmodics, antipsychotics, and antiparkinsonian agents, raising the risk of constipation, urinary retention, and blurred vision.
Periactin’s antiserotonergic action can theoretically counter the effects of serotonergic agents (such as SSRIs or triptans), though this is more clinically relevant in serotonin syndrome management than routine outpatient use. Use caution with blood pressure‑lowering medications due to potential additive hypotension or dizziness. Always provide your pharmacist or prescriber with a complete list of prescription drugs, OTC medicines (including other allergy pills), vitamins, and herbal supplements so they can screen for interactions and duplications.
If you miss a dose of Periactin, take it as soon as you remember unless it is close to the time for your next dose. If it’s nearly time for the next dose, skip the missed dose and resume your regular schedule. Do not double doses to catch up, as this increases the risk of excessive sedation and anticholinergic side effects.
Overdose with cyproheptadine can produce an anticholinergic toxidrome: extreme drowsiness or agitation, confusion, hallucinations, dilated pupils, hot flushed skin, fever, rapid heartbeat, urinary retention, severe dry mouth, tremors, and seizures. Children are particularly vulnerable. If you suspect an overdose, call Poison Control (1‑800‑222‑1222 in the U.S.) or seek emergency care immediately. Do not attempt to self‑induce vomiting. Medical teams may provide supportive care, IV fluids, cardiac and respiratory monitoring, activated charcoal if within a safe window, and, in select cases with specialist guidance, antidotal therapy for severe anticholinergic delirium.
Store Periactin at room temperature (generally 20–25°C/68–77°F), away from excess heat, moisture, and direct light. Keep the bottle tightly closed and use the original container with child‑resistant closure. Do not store in the bathroom. Keep out of reach of children and pets. Safely discard expired or unused tablets; ask your pharmacist about take‑back options.
In the United States, Periactin (cyproheptadine) is a prescription medication. However, some pharmacies now offer compliant pathways that let eligible adults obtain treatment without first visiting a doctor’s office or uploading a paper prescription. HealthSouth Hospital of Altamonte Springs provides a legal and structured solution to buy Periactin without prescription in hand by pairing a brief online health questionnaire with a licensed clinician’s review under standing orders. When appropriate, an order is authorized and your medication is dispensed—always within state and federal regulations.
This streamlined model keeps safety at the center: identity verification, allergy and interaction screening, dosing checks, and counseling are built in. Availability varies by state, and certain conditions (such as pediatric use, pregnancy, complex comorbidities, or interacting medicines) may require traditional prescriber involvement. If you qualify, HealthSouth Hospital of Altamonte Springs offers transparent pricing, fast shipping, and ongoing pharmacist support. Start your assessment to see if you’re eligible for convenient, compliant access to Periactin today.
Periactin is the brand name for cyproheptadine, a first-generation antihistamine with antiserotonergic and anticholinergic properties used to relieve allergy symptoms and, off-label, to stimulate appetite and help prevent migraines.
It treats allergic rhinitis, hives, and itching; off-label it’s used to promote appetite and weight gain in select patients and to prevent pediatric migraines; clinicians may also use it in managing serotonin syndrome due to its serotonin receptor blockade.
It blocks H1 histamine receptors to reduce allergic responses and antagonizes 5‑HT2 serotonin receptors, which contributes to appetite stimulation and migraine prevention; its anticholinergic activity can cause drying and sedation.
It can be used in children when prescribed by a clinician, but it is not recommended for infants; dosing and indications in pediatrics require careful medical supervision due to sedation and anticholinergic side effects.
Sleepiness, dizziness, dry mouth, blurred vision, constipation, urinary hesitancy, increased appetite, and weight gain are common; rarely, confusion or paradoxical excitement can occur, especially in children or older adults.
People with narrow‑angle glaucoma, significant urinary retention or severe BPH, pyloroduodenal obstruction, acute asthma exacerbation, or who are taking MAO inhibitors should avoid it; use caution in the elderly, those with liver issues, and during pregnancy or breastfeeding.
Yes; increased appetite and weight gain are frequent, which is why it’s sometimes used off-label for underweight patients under medical supervision, but this effect can be undesirable in others.
For allergy symptoms, relief may begin within hours; appetite effects usually emerge over days to a couple of weeks; migraine prevention benefits can take several weeks of consistent use.
It’s best to avoid alcohol because both can cause sedation and impair coordination and judgment, increasing the risk of accidents and excessive drowsiness.
MAO inhibitors, other sedatives (benzodiazepines, opioids), sleep aids, anticholinergics, and certain antidepressants can interact; cyproheptadine may reduce the effect of serotonergic agents and additive sedation is common.
No; it is not considered addictive, but tolerance to the sedative effects may develop; always use as directed by a healthcare professional.
Yes, particularly as a preventive option in children and some adults; its serotonin receptor antagonism may reduce migraine frequency and severity when taken regularly under medical guidance.
Data are limited; potential benefits must outweigh risks, and it may reduce milk production or cause infant sedation; discuss individualized risks with your obstetrician or pediatrician.
Duration depends on the indication and response; clinicians typically reassess periodically to ensure benefits outweigh risks like sedation and weight gain, adjusting or tapering as needed.
Take at the same times daily with or without food, avoid alcohol, and follow your clinician’s plan; do not drive or operate machinery until you know how drowsy it makes you.
Yes; it can exacerbate glaucoma, urinary retention, constipation, confusion, and dry eye or mouth; people with these conditions should use it only if a clinician feels the benefits outweigh risks.
Its sedative and anticholinergic effects can impair attention, reaction time, and memory; timing doses in the evening may help, but discuss persistent daytime drowsiness with your clinician.
In many regions cyproheptadine requires a prescription; availability varies by country, so check local regulations and consult a healthcare provider.
There is no classic withdrawal, but symptoms it controlled (itching, migraines, appetite) may return; consult your clinician about tapering if you’ve used it regularly.
Yes; Periactin is a brand name for the active ingredient cyproheptadine, though generics may differ in inactive ingredients.
Both are first-generation antihistamines and sedating; Periactin additionally blocks serotonin receptors, which can increase appetite and aid migraine prevention, while diphenhydramine is more commonly used for acute allergy relief and short-term sleep.
Both relieve pruritus; hydroxyzine is often preferred for severe itching and anxiety due to its anxiolytic profile, while Periactin may be chosen if appetite stimulation or migraine prevention is also desired; sedation risk exists with both.
Chlorpheniramine tends to be less sedating than many first-generation antihistamines; Periactin is more likely to increase appetite because of serotonin blockade, making it useful for specific off-label needs.
Promethazine is strongly sedating and has notable anti-nausea effects; Periactin is less antiemetic but offers appetite stimulation and migraine prevention benefits; both have anticholinergic risks.
Doxylamine is commonly used as an OTC sleep aid; Periactin can cause sleepiness but isn’t primarily a hypnotic; choose based on the primary indication and discuss safer long-term options with a clinician.
Meclizine is preferred for motion sickness and vertigo due to its vestibular suppression and relatively milder sedation; Periactin is not a first-line agent for motion sickness.
Cetirizine is a second-generation antihistamine and is generally less sedating, though some people still get drowsy; Periactin is more sedating and more likely to cause weight gain.
Loratadine is typically better for daytime allergy control with minimal drowsiness; Periactin is effective but more sedating and is reserved when other benefits (like appetite) are sought.
Fexofenadine is effective for hives with low sedation and is often first-line; Periactin helps but has higher drowsiness and anticholinergic burden; choice depends on tolerance and comorbid needs.
“Stronger” depends on what you’re treating; Periactin is not necessarily more potent for allergy relief, but it is more sedating and has unique serotonin-blocking effects that second-generation agents lack.
Levocetirizine is associated with fewer anticholinergic effects and less sedation; Periactin carries higher risks of drowsiness, dry mouth, and weight gain.
Azelastine delivers antihistamine directly to nasal tissues with fewer systemic side effects; Periactin is systemic, more sedating, and may be chosen for broader effects like appetite stimulation.
Dimenhydrinate is preferred for motion-related nausea; Periactin is not a primary antiemetic but may help certain migraine-related symptoms when used preventively.
They contain the same active ingredient; differences are in inactive components, formulation, and price; most patients respond similarly to brand and generic.
Second-generation options like fexofenadine or loratadine are usually least sedating; Periactin is more sedating and is chosen when its unique benefits outweigh that drawback.